fda approves first oral glp-1 obesity drug august 21 2025 The has approved Foundayo, Eli Lilly's once-daily weight-loss pill, adding another option to a rapidly expanding class of treatments. Its active ingredient, orforglipron, is a drug, meaning it mimics GLP-1 Pipeline Update: August 2025
Pay in 4 interest-free payments of $5.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19





:max_bytes(150000):strip_icc()/VWH-GettyImages-2158519129-372ed708fbbb4c6e9f472a8218cd52ee.jpg)















